Abstract
The production of therapeutic proteins in plant seed augments alternative production platforms such as microbial fermentation, cell-based systems, transgenic animals, and other recombinant plant production systems to meet increasing demands for the existing biologics, drugs under evaluation, and undiscovered therapeutics in the future. We have developed upstream purification technologies for oilseeds which are designed to cost-effectively purify therapeutic proteins amenable to conventional downstream manufacture. A very useful tool in these endeavors is the plant model system Arabidopsis thaliana. The current chapter describes the rationale and methods used to over-express potential therapeutic products in A. thaliana seed for evaluation and definitive insight into whether our production platform, Safflower, can be utilized for large-scale manufacture.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Obembe OO et al (2010) Advances in plant molecular farming. Biotechnol Adv 29(2):210–222
Sourrouille C et al (2009) From Neanderthal to nanobiotech: from plant potions to pharming with plant factories. Methods Mol Biol 483:1–23
Ma JK et al (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4:794–805
Twyman RM et al (2003) Molecular farming in plants: host systems and expression technology. Trends Biotechnol 21(12):570–578
Davies HM (2010) Commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnol J 8:854–861
Dunwell JM (2011) Foresight project on global food and farming futures. Crop biotechnology: prospects and opportunities. J Agric Sci 149:17–27
Castilho A et al (2010) In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 285(21):15923–15930
De Muynck B et al (2010) Production of antibodies in plants: status after twenty years. Plant Biotechnol J 8:529–563
Loos A et al (2010) Production of monoclonal antibodies with a controlled N-glycosylation pattern in seeds of Arabidopsis thaliana. Plant Biotechnol J 9(2):179–192
Loos A et al (2011) Expression of antibody fragments with a controlled N-glycosylation pattern and induction of ER-derived vesicles in seeds in Arabidopsis thaliana. Plant Physiol 155:2036–2048
Boothe J et al (2010) Seed-based expression systems for plant molecular farming. Plant Biotechnol J 8:588–606
Markley N et al (2006) Producing proteins using transgenic oilbody oleosin technology. Biopharm Int 19:34–47
The Arabidopsis Genome Initiative (2000) Analysis of the genome sequence of the flowering plant Arabidopsis thaliana. Nature 408:796–815
Koornneef M, Meinke D (2010) The development of Arabidopsis as a model plant. Plant J 61:909–921
Rounsley SD, Last RL (2010) Shotguns and SNPs: how fast and cheap sequencing is revolutionizing plant biology. Plant J 61:922–927
Liu Y-G et al (1995) Efficient isolation and mapping of Arabidopsis thaliana T-DNA insert junctions by thermal asymmetric interlaced PCR. Plant J 8(3):457–463
Nykiforuk CL et al (2006) Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnol J 4:77–85
Clough SJ, Bent AF (1998) Floral dip: a simplified method for Agrobacterium-mediated transformation of Arabidopsis thaliana. Plant J 16(6):735–743
Van Rooijen GJH, Moloney MM (1995) Structural requirements of oleosin domains for subcellular targeting to the oil body. Plant Physiol 109:1353–1361
Hajdukiewicz P et al (1994) The small, versatile pPZP family of Agrobacterium binary vectors for plant transformation. Plant Mol Biol 25:989–994
Hood EH et al (1986) The hypervirulence of Agrobacterium tumefaciens A281 is encoded in a region of pTiBo542 outside of T-DNA. J Bacteriol 168(3):1291–1301
Hellens R et al (2000) A guide to Agrobacterium binary Ti vectors. Trends Plant Sci 5(10):446–451
Inoue H et al (1990) High efficiency transformation of Escherichia coli with plasmids. Gene 96:23–28
Schneitz K et al (1995) Wild-type ovule development in Arabidopsis thaliana: a light microscope study of cleared whole-mount tissue. Plant J 7(5):731–749
Lee L-Y, Gelvin SB (2008) T-DNA binary vectors and systems. Plant Physiol 146:325–332
Luo ZQ, Farrand SK (1999) Cloning and characterization of a tetracycline resistance determinant present in Agrobacterium tumefaciens C58. J Bacteriol 181:618–626
Cheng AM et al (1998) Timentin as an alternative antibiotic for suppression of Agrobacterium tumefaciens in genetic transformation. Plant Cell Rep 17:646–649
Kjeldsen T et al (2001) Expression of insulin in yeast: the importance of molecular adaptation for secretion and conversion. Biotechnol Genet Eng Rev 18:89–121
Slightom JL et al (1983) Complete nucleotide sequence of a French bean storage protein gene: phaseolin. Proc Natl Acad Sci USA 80:1897–1901
Abell BM et al (2002) Membrane protein topology of oleosin is constrained by its long hydrophobic domain. J Biol Chem 277(10):8602–8610
Abell BM et al (2004) Membrane topology and sequence requirements for oilbody targeting of oleosin. Plant J 37:461–470
Wohlleben W et al (1988) Nucleotide sequence of the phophinothricin N-acetyltransferase gene from Streptomyces viridochromogenes TA1/4494 and its expression in Nicotiana tabacum. Gene 70:25–37
Kawalleck P et al (1993) Polyubiquitin gene expression and structural properties of the ubi4-2 gene in Petroselinum crispum. Plant Mol Biol 21:673–684
Stoger E et al (2005) Sowing the seeds of success: pharmaceutical proteins from plants. Curr Opin Biotechnol 16:167–173
Rothstein SJ et al (1987) Promoter cassettes, antibiotic-resistance genes, and vectors for plant transformation. Gene 53:153–161
Georgiou G, Valax P (1996) Expression of correctly folded proteins in Escherichia coli. Curr Opin Biotechnol 7:190–197
Nykiforuk CL et al (2011) Expression and recovery of biologically active recombinant Apolipoprotein AIMilano from transgenic safflower (Carthamus tinctorius) seeds. Plant Biotechnol J 9(2):250–263
Kühnel B et al (2003) Precise and efficient cleavage of recombinant fusion proteins using mammalian aspartic proteases. Protein Eng 16(10):777–783
Schechter I, Berger A (1967) On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun 27(2):157–162
Schechter I, Berger A (1968) On the active site of proteases. III. Mapping the active site of papain; specific peptide inhibitors of papain. Biochem Biophys Res Commun 32(5):898–902
Keil B (1992) Specificity of proteolysis. Springer–Verlag, Berlin/Heidelberg/New York, p 335
Nagai K et al (1985) Oxygen binding properties of human mutant hemoglobins synthesized in Escherichia coli. Proc Natl Acad Sci USA 82:7252–7255
LaVallie ER et al (1993) Cloning and functional expression of a cDNA encoding the catalytic subunit of bovine enterokinase. J Biol Chem 268:23311–23317
Geng Y et al (2010) Expression of active recombinant human tissue-type plasminogen activator by using in vivo polyhydroxybutyrate granule display. Appl Environ Microbiol 76(21):7226–7230
Bader O et al (2008) Processing of predicted substrates of fungal Kex2 proteinases from Candida albicans, C. glabrata, Saccharomyces cerevisiae and Pichia pastoris. BMC Microbiol 8:1–16
Nilsson CP et al (1989) Engineering substilisin BPN’ for site-specific proteolysis. Proteins 6(3):240–248
Kahle NA et al (2010) Furin cleavage of bacterial expressed glutathione-S-transferase-pro-transforming growth factor β1 fusion protein in vitro. Protein Pept Lett 17(4):416–418
Chong S et al (1997) Single-column purification of free recombinant proteins using a self-cleavable affinity tag derived from a protein splicing element. Gene 192:277–281
Butt TR et al (2005) SUMO fusion technology for difficult-to-express proteins. Protein Expr Purif 43:1–9
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Nykiforuk, C.L., Boothe, J.G. (2012). Transgenic Expression of Therapeutic Proteins in Arabidopsis thaliana Seed. In: Voynov, V., Caravella, J. (eds) Therapeutic Proteins. Methods in Molecular Biology, vol 899. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-921-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-61779-921-1_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-920-4
Online ISBN: 978-1-61779-921-1
eBook Packages: Springer Protocols